Doug Drysdale (@insidepharma) on X (Twitter)
This page is public and can appear in search results. The audience and topic lines below are AI-inferred and may be wrong.
Claim this page → · Correct it, take it out of search, or remove it →
Doug Drysdale is a creator on X (Twitter) in the 2K–3K follower range, publishing for Biopharma executives, operators and strategic advisors focused on drug commercialization, M&A and capital strategy, based in United States. Profile last checked 2026-07-03.
Observed facts (from the public profile):
| Field | Value |
|---|---|
| Platform | X (Twitter) |
| Handle | @insidepharma |
| Followers | 2K–3K |
| Market | United States |
Profile bio
Biopharma Operator & Strategic Advisor / Founder, Katogen / Board Member / PubCo CEO / M&A, Capital Strategy / Read My Newsletter: https://t.co/CISSuxuCBe
What this creator posts about, and who reads it (AI-inferred)
Audience: Biopharma executives, operators and strategic advisors focused on drug commercialization, M&A and capital strategy
Provenance: inferred by AI from public content, not stated by the creator — confidence 0.40 · read from 2 recent posts · updated 85 days ago.
Audience read from this creator’s own recent posts, not from platform-declared categories. It is our reading, and it can be wrong.
Recent content samples (what the inference above was drawn from)
https://t.co/Op14cg2Zvc
A migraine drug that works is worth nothing if the patient stops taking it. The CGRP class taught the field a lesson most people still have not absorbed. Eight products approved since 2018. First new prevention…
See the original post on X (Twitter)
Where this creator sits among comparable accounts
Compared with the 3,045 accounts in the same group (x · nano · software):
| Dimension | Percentile in group |
|---|---|
| Overall | 81st |
| Authenticity | 69th |
| Focus & activity | 66th |
This is a position, not a verdict. A percentile says where this account falls among comparable accounts on signals we can measure — it does not say this creator is a better fit for your campaign. We ran a blind benchmark and measured no reliable advantage in selection quality, and do not claim one.
See the Creator Index Report for how this index is structured.
Other X (Twitter) creators in this index
- insMind (@insmind_com) — AI ad creative workflows
- Insomnia (@insomnia_vip) — AI agents for business building
- Inteligencia Artificial (@inteligencia_x) — Anthropic and Claude developments
- InteractiveST (@interactiveGTS) — AI-RPG game development and publishing
- inventtatte 💙 Marketing Online 💙 Automa 💙 IA (@inventtatt — Online Marketing
- QuantumEdge (@invest2wealth) — Stock portfolio analysis
- I N V E S T A A 🎒 (@investaadharsh) — Crypto casino
- Investor Savage❤️🔥❤️🔥 (@investor_savag) — Web3 consistency
Creators next to this one by follower tier in the same slice. Each link opens that creator’s public profile — what they post about and who reads it, with no contact details.
This page lists public profile information only. It carries no contact details and no authenticity score. If you are Doug Drysdale and want this page removed, request removal.
Machine-readable representations
Structured twins of this page for AI and agents — every inferred field carries its source, confidence and freshness.
AI retrieval activity
What AI systems have actually done with this page. The two kinds are counted separately: being indexed is not the same as being used.
| Kind | Requests | What it means |
|---|---|---|
| Indexing crawlers | 6 | Bulk indexing · Amazonbot, Applebot, ClaudeBot |
| User-triggered retrievals | 0 | none recorded yet |
Is this you? Claim this page.
Claim it to verify your identity, correct anything we got wrong, and add context only you have. Free, no account needed.
Claim this page →